The global nucleotide market size is expected to reach USD 1,377.25 million by 2030, registering a CAGR of 7.12% from 2023 to 2030. The global nucleotide market is expected to witness substantial growth over the forecast period owing to its widespread use in pharmaceuticals and food & beverage industries. Diagnostic research along with pharmaceutical applications dominated the nucleotide market owning to properties including enhanced immunity, positive effects on the intestines, and positive effects of recovery from stress. In addition, growing R&D in the field of dietary nucleotide coupled with yeast-derived nucleotide for livestock nutrition across the globe is expected to propel demand over the forecast period.
Nucleotide Market Report Highlights
- The TaqMan allelic discrimination segment dominated the global market in 2022, followed by SNP by pyrosequencing
- The diagnostics research segment dominated the global market for nucleotides in 2022
- The deoxy nucleotides (dNTPs) segment dominated the global nucleotide market in 2022 with a revenue share of 47.49% and is furthermore likely to expand with the fastest CAGR of 7.34% over the forecast period
- Asia Pacific is expected to witness the fastest growth among other regions, growing at a CAGR of 7.81% from 2023 to 2030. The presence of the leading nucleotide manufacturer in the region coupled with increasing demand for nutraceuticals and the health food industry is expected to increase demand for the product. In addition, increasing food & beverage additive explorations particularly Asia Pacific is likely to propel market growth for nucleotide over the forecast period
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Technology
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.1.1. Product
1.1.2. Technology
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Nucleotides Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Nucleotides Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Nucleotides Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Nucleotides Market: Product Estimates & Trend Analysis
4.1. Nucleotides Market: Key Takeaways
4.2. Nucleotides Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Deoxy Nucleotides
4.3.1. Deoxy Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. By production method
4.3.1.1.1. Enzyme sourced
4.3.1.1.2. Chemical synthesis
4.4. Dideoxynucleotides
4.4.1. Dideoxynucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Nucleotides for RNA Synthesis (rNTP)
4.5.1. Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Labelled Nucleotides
4.6.1. Labelled Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.2. Nucleotides Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Deoxy Nucleotides
4.3.1. Deoxy Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. By production method
4.3.1.1.1. Enzyme sourced
4.3.1.1.2. Chemical synthesis
4.4. Dideoxynucleotides
4.4.1. Dideoxynucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Nucleotides for RNA Synthesis (rNTP)
4.5.1. Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Labelled Nucleotides
4.6.1. Labelled Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Nucleotides Market: Technology Estimates & Trend Analysis
5.1. Nucleotides Market: Key Takeaways
5.2. Nucleotides Market: Technology Movement & Market Share Analysis, 2022 & 2030
5.3. TaqMan Allelic Discrimination
5.3.1. TaqMan allelic discrimination market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Gene Chips & microarrays
5.4.1. Gene chips & microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. SNP by Pyrosequencing
5.5.1. SNP by pyrosequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.2. Nucleotides Market: Technology Movement & Market Share Analysis, 2022 & 2030
5.3. TaqMan Allelic Discrimination
5.3.1. TaqMan allelic discrimination market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Gene Chips & microarrays
5.4.1. Gene chips & microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. SNP by Pyrosequencing
5.5.1. SNP by pyrosequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Nucleotides Market: Application Estimates & Trend Analysis
6.1. Nucleotides Market: Key Takeaways
6.2. Nucleotides Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Pharmaceuticals
6.3.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diagnostics Research
6.4.1. Diagnostics research market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Food & Beverage Additive
6.5.1. Food & beverage additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Animal Feed Additive
6.6.1. Animal feed additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
6.2. Nucleotides Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Pharmaceuticals
6.3.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diagnostics Research
6.4.1. Diagnostics research market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Food & Beverage Additive
6.5.1. Food & beverage additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Animal Feed Additive
6.6.1. Animal feed additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Nucleotides Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Nucleotides Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.2. Nucleotides Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. CJ CHEILJEDANG CORP
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Star Lake Bioscience Co., Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Thermo Fisher Scientific Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. MEIHUA HOLDINGS GROUP CO., LTD.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. F. Hoffmann-La Roche Ltd.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Biorigin
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. DSM Nutritional Products AG
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Promega Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Agilent Technologies Inc.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Lallemand Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Nanjing Biotogether Co., Ltd.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. NuEra Nutraceuticals Inc.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. Ohly
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives
8.2. Market Participant Categorization
8.2.1. CJ CHEILJEDANG CORP
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Star Lake Bioscience Co., Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Thermo Fisher Scientific Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. MEIHUA HOLDINGS GROUP CO., LTD.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. F. Hoffmann-La Roche Ltd.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Biorigin
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. DSM Nutritional Products AG
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Promega Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Agilent Technologies Inc.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Lallemand Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Nanjing Biotogether Co., Ltd.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. NuEra Nutraceuticals Inc.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. Ohly
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America nucleotides market, by product, 2018-2030 (USD Million)
Table 3 North America nucleotides market, by technology, 2018-2030 (USD Million)
Table 4 North America nucleotides market, by application, 2018-2030 (USD Million)
Table 5 North America nucleotides market, by region, 2018-2030 (USD Million)
Table 6 U.S. nucleotides market, by product, 2018-2030 (USD Million)
Table 7 U.S. nucleotides market, by technology, 2018-2030 (USD Million)
Table 8 U.S. nucleotides market, by application, 2018-2030 (USD Million)
Table 9 Canada nucleotides market, by product, 2018-2030 (USD Million)
Table 10 Canada nucleotides market, by technology, 2018-2030 (USD Million)
Table 11 Canada nucleotides market, by application, 2018-2030 (USD Million)
Table 12 Europe nucleotides market, by product, 2018-2030 (USD Million)
Table 13 Europe nucleotides market, by technology, 2018-2030 (USD Million)
Table 14 Europe nucleotides market, by application, 2018-2030 (USD Million)
Table 15 Europe nucleotides market, by region, 2018-2030 (USD Million)
Table 16 Germany nucleotides market, by product, 2018-2030 (USD Million)
Table 17 Germany nucleotides market, by technology, 2018-2030 (USD Million)
Table 18 Germany nucleotides market, by application, 2018-2030 (USD Million)
Table 19 UK nucleotides market, by product, 2018-2030 (USD Million)
Table 20 UK nucleotides market, by technology, 2018-2030 (USD Million)
Table 21 UK nucleotides market, by application, 2018-2030 (USD Million)
Table 22 France nucleotides market, by product, 2018-2030 (USD Million)
Table 23 France nucleotides market, by technology, 2018-2030 (USD Million)
Table 24 France nucleotides market, by application, 2018-2030 (USD Million)
Table 25 Italy nucleotides market, by product, 2018-2030 (USD Million)
Table 26 Italy nucleotides market, by technology, 2018-2030 (USD Million)
Table 27 Italy nucleotides market, by application, 2018-2030 (USD Million)
Table 28 Spain nucleotides market, by product, 2018-2030 (USD Million)
Table 29 Spain nucleotides market, by technology, 2018-2030 (USD Million)
Table 30 Spain nucleotides market, by application, 2018-2030 (USD Million)
Table 31 Denmark nucleotides market, by product, 2018-2030 (USD Million)
Table 32 Denmark nucleotides market, by technology, 2018-2030 (USD Million)
Table 33 Denmark nucleotides market, by application, 2018-2030 (USD Million)
Table 34 Sweden nucleotides market, by product, 2018-2030 (USD Million)
Table 35 Sweden nucleotides market, by technology, 2018-2030 (USD Million)
Table 36 Sweden nucleotides market, by application, 2018-2030 (USD Million)
Table 37 Norway nucleotides market, by product, 2018-2030 (USD Million)
Table 38 Norway nucleotides market, by technology, 2018-2030 (USD Million)
Table 39 Norway nucleotides market, by application, 2018-2030 (USD Million)
Table 40 Asia Pacific nucleotides market, by product, 2018-2030 (USD Million)
Table 41 Asia Pacific nucleotides market, by technology, 2018-2030 (USD Million)
Table 42 Asia Pacific nucleotides market, by application, 2018-2030 (USD Million)
Table 43 Asia Pacific nucleotides market, by region, 2018-2030 (USD Million)
Table 44 Japan nucleotides market, by product, 2018-2030 (USD Million)
Table 45 Japan nucleotides market, by technology, 2018-2030 (USD Million)
Table 46 Japan nucleotides market, by application, 2018-2030 (USD Million)
Table 47 China nucleotides market, by product, 2018-2030 (USD Million)
Table 48 China nucleotides market, by technology, 2018-2030 (USD Million)
Table 49 China nucleotides market, by application, 2018-2030 (USD Million)
Table 50 India nucleotides market, by product, 2018-2030 (USD Million)
Table 51 India nucleotides market, by technology, 2018-2030 (USD Million)
Table 52 India nucleotides market, by application, 2018-2030 (USD Million)
Table 53 Australia nucleotides market, by product, 2018-2030 (USD Million)
Table 54 Australia nucleotides market, by technology, 2018-2030 (USD Million)
Table 55 Australia nucleotides market, by application, 2018-2030 (USD Million)
Table 56 Thailand nucleotides market, by product, 2018-2030 (USD Million)
Table 57 Thailand nucleotides market, by technology, 2018-2030 (USD Million)
Table 58 Thailand nucleotides market, by application, 2018-2030 (USD Million)
Table 59 South Korea nucleotides market, by product, 2018-2030 (USD Million)
Table 60 South Korea nucleotides market, by technology, 2018-2030 (USD Million)
Table 61 South Korea nucleotides market, by application, 2018-2030 (USD Million)
Table 62 Latin America nucleotides market, by product, 2018-2030 (USD Million)
Table 63 Latin America nucleotides market, by technology, 2018-2030 (USD Million)
Table 64 Latin America nucleotides market, by application, 2018-2030 (USD Million)
Table 65 Latin America nucleotides market, by region, 2018-2030 (USD Million)
Table 66 Brazil nucleotides market, by product, 2018-2030 (USD Million)
Table 67 Brazil nucleotides market, by technology, 2018-2030 (USD Million)
Table 68 Brazil nucleotides market, by application, 2018-2030 (USD Million)
Table 69 Mexico nucleotides market, by product, 2018-2030 (USD Million)
Table 70 Mexico nucleotides market, by technology, 2018-2030 (USD Million)
Table 71 Mexico nucleotides market, by application, 2018-2030 (USD Million)
Table 72 Argentina nucleotides market, by product, 2018-2030 (USD Million)
Table 73 Argentina nucleotides market, by technology, 2018-2030 (USD Million)
Table 74 Argentina nucleotides market, by application, 2018-2030 (USD Million)
Table 75 Middle East and Africa nucleotides market, by product, 2018-2030 (USD Million)
Table 76 Middle East and Africa nucleotides market, by technology, 2018-2030 (USD Million)
Table 77 Middle East and Africa nucleotides market, by application, 2018-2030 (USD Million)
Table 78 Middle East and Africa nucleotides market, by region, 2018-2030 (USD Million)
Table 79 South Africa nucleotides market, by product, 2018-2030 (USD Million)
Table 80 South Africa nucleotides market, by technology, 2018-2030 (USD Million)
Table 81 South Africa nucleotides market, by application, 2018-2030 (USD Million)
Table 82 Saudi Arabia nucleotides market, by product, 2018-2030 (USD Million)
Table 83 Saudi Arabia nucleotides market, by technology, 2018-2030 (USD Million)
Table 84 Saudi Arabia nucleotides market, by application, 2018-2030 (USD Million)
Table 85 UAE nucleotides market, by product, 2018-2030 (USD Million)
Table 86 UAE nucleotides market, by technology, 2018-2030 (USD Million)
Table 87 UAE nucleotides market, by application, 2018-2030 (USD Million)
Table 88 Kuwait nucleotides market, by product, 2018-2030 (USD Million)
Table 89 Kuwait nucleotides market, by technology, 2018-2030 (USD Million)
Table 90 Kuwait nucleotides market, by application, 2018-2030 (USD Million)
Table 2 North America nucleotides market, by product, 2018-2030 (USD Million)
Table 3 North America nucleotides market, by technology, 2018-2030 (USD Million)
Table 4 North America nucleotides market, by application, 2018-2030 (USD Million)
Table 5 North America nucleotides market, by region, 2018-2030 (USD Million)
Table 6 U.S. nucleotides market, by product, 2018-2030 (USD Million)
Table 7 U.S. nucleotides market, by technology, 2018-2030 (USD Million)
Table 8 U.S. nucleotides market, by application, 2018-2030 (USD Million)
Table 9 Canada nucleotides market, by product, 2018-2030 (USD Million)
Table 10 Canada nucleotides market, by technology, 2018-2030 (USD Million)
Table 11 Canada nucleotides market, by application, 2018-2030 (USD Million)
Table 12 Europe nucleotides market, by product, 2018-2030 (USD Million)
Table 13 Europe nucleotides market, by technology, 2018-2030 (USD Million)
Table 14 Europe nucleotides market, by application, 2018-2030 (USD Million)
Table 15 Europe nucleotides market, by region, 2018-2030 (USD Million)
Table 16 Germany nucleotides market, by product, 2018-2030 (USD Million)
Table 17 Germany nucleotides market, by technology, 2018-2030 (USD Million)
Table 18 Germany nucleotides market, by application, 2018-2030 (USD Million)
Table 19 UK nucleotides market, by product, 2018-2030 (USD Million)
Table 20 UK nucleotides market, by technology, 2018-2030 (USD Million)
Table 21 UK nucleotides market, by application, 2018-2030 (USD Million)
Table 22 France nucleotides market, by product, 2018-2030 (USD Million)
Table 23 France nucleotides market, by technology, 2018-2030 (USD Million)
Table 24 France nucleotides market, by application, 2018-2030 (USD Million)
Table 25 Italy nucleotides market, by product, 2018-2030 (USD Million)
Table 26 Italy nucleotides market, by technology, 2018-2030 (USD Million)
Table 27 Italy nucleotides market, by application, 2018-2030 (USD Million)
Table 28 Spain nucleotides market, by product, 2018-2030 (USD Million)
Table 29 Spain nucleotides market, by technology, 2018-2030 (USD Million)
Table 30 Spain nucleotides market, by application, 2018-2030 (USD Million)
Table 31 Denmark nucleotides market, by product, 2018-2030 (USD Million)
Table 32 Denmark nucleotides market, by technology, 2018-2030 (USD Million)
Table 33 Denmark nucleotides market, by application, 2018-2030 (USD Million)
Table 34 Sweden nucleotides market, by product, 2018-2030 (USD Million)
Table 35 Sweden nucleotides market, by technology, 2018-2030 (USD Million)
Table 36 Sweden nucleotides market, by application, 2018-2030 (USD Million)
Table 37 Norway nucleotides market, by product, 2018-2030 (USD Million)
Table 38 Norway nucleotides market, by technology, 2018-2030 (USD Million)
Table 39 Norway nucleotides market, by application, 2018-2030 (USD Million)
Table 40 Asia Pacific nucleotides market, by product, 2018-2030 (USD Million)
Table 41 Asia Pacific nucleotides market, by technology, 2018-2030 (USD Million)
Table 42 Asia Pacific nucleotides market, by application, 2018-2030 (USD Million)
Table 43 Asia Pacific nucleotides market, by region, 2018-2030 (USD Million)
Table 44 Japan nucleotides market, by product, 2018-2030 (USD Million)
Table 45 Japan nucleotides market, by technology, 2018-2030 (USD Million)
Table 46 Japan nucleotides market, by application, 2018-2030 (USD Million)
Table 47 China nucleotides market, by product, 2018-2030 (USD Million)
Table 48 China nucleotides market, by technology, 2018-2030 (USD Million)
Table 49 China nucleotides market, by application, 2018-2030 (USD Million)
Table 50 India nucleotides market, by product, 2018-2030 (USD Million)
Table 51 India nucleotides market, by technology, 2018-2030 (USD Million)
Table 52 India nucleotides market, by application, 2018-2030 (USD Million)
Table 53 Australia nucleotides market, by product, 2018-2030 (USD Million)
Table 54 Australia nucleotides market, by technology, 2018-2030 (USD Million)
Table 55 Australia nucleotides market, by application, 2018-2030 (USD Million)
Table 56 Thailand nucleotides market, by product, 2018-2030 (USD Million)
Table 57 Thailand nucleotides market, by technology, 2018-2030 (USD Million)
Table 58 Thailand nucleotides market, by application, 2018-2030 (USD Million)
Table 59 South Korea nucleotides market, by product, 2018-2030 (USD Million)
Table 60 South Korea nucleotides market, by technology, 2018-2030 (USD Million)
Table 61 South Korea nucleotides market, by application, 2018-2030 (USD Million)
Table 62 Latin America nucleotides market, by product, 2018-2030 (USD Million)
Table 63 Latin America nucleotides market, by technology, 2018-2030 (USD Million)
Table 64 Latin America nucleotides market, by application, 2018-2030 (USD Million)
Table 65 Latin America nucleotides market, by region, 2018-2030 (USD Million)
Table 66 Brazil nucleotides market, by product, 2018-2030 (USD Million)
Table 67 Brazil nucleotides market, by technology, 2018-2030 (USD Million)
Table 68 Brazil nucleotides market, by application, 2018-2030 (USD Million)
Table 69 Mexico nucleotides market, by product, 2018-2030 (USD Million)
Table 70 Mexico nucleotides market, by technology, 2018-2030 (USD Million)
Table 71 Mexico nucleotides market, by application, 2018-2030 (USD Million)
Table 72 Argentina nucleotides market, by product, 2018-2030 (USD Million)
Table 73 Argentina nucleotides market, by technology, 2018-2030 (USD Million)
Table 74 Argentina nucleotides market, by application, 2018-2030 (USD Million)
Table 75 Middle East and Africa nucleotides market, by product, 2018-2030 (USD Million)
Table 76 Middle East and Africa nucleotides market, by technology, 2018-2030 (USD Million)
Table 77 Middle East and Africa nucleotides market, by application, 2018-2030 (USD Million)
Table 78 Middle East and Africa nucleotides market, by region, 2018-2030 (USD Million)
Table 79 South Africa nucleotides market, by product, 2018-2030 (USD Million)
Table 80 South Africa nucleotides market, by technology, 2018-2030 (USD Million)
Table 81 South Africa nucleotides market, by application, 2018-2030 (USD Million)
Table 82 Saudi Arabia nucleotides market, by product, 2018-2030 (USD Million)
Table 83 Saudi Arabia nucleotides market, by technology, 2018-2030 (USD Million)
Table 84 Saudi Arabia nucleotides market, by application, 2018-2030 (USD Million)
Table 85 UAE nucleotides market, by product, 2018-2030 (USD Million)
Table 86 UAE nucleotides market, by technology, 2018-2030 (USD Million)
Table 87 UAE nucleotides market, by application, 2018-2030 (USD Million)
Table 88 Kuwait nucleotides market, by product, 2018-2030 (USD Million)
Table 89 Kuwait nucleotides market, by technology, 2018-2030 (USD Million)
Table 90 Kuwait nucleotides market, by application, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Nucleotides: Market outlook
Fig. 8 Nucleotides: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Nucleotides market driver impact
Fig. 14 Nucleotides market restraint impact
Fig. 15 Nucleotides market strategic initiatives analysis
Fig. 16 Nucleotides market: Product movement analysis
Fig. 17 Nucleotides market: Product outlook and key takeaways
Fig. 18 Deoxy Nucleotides market estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 Dideoxynucleotides market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Labelled Nucleotides market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 Nucleotides market: Technology movement analysis
Fig. 23 Nucleotides market: Technology outlook and key takeaways
Fig. 24 TaqMan allelic discrimination market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Gene chips & microarrays market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 SNP by pyrosequencing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Nucleotides market: Application movement analysis
Fig. 29 Nucleotides market: Application outlook and key takeaways
Fig. 30 Pharmaceuticals market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Diagnostics research market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Food & beverage additive market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Animal feed additive market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 Global nucleotides market: Regional movement analysis
Fig. 36 Global nucleotides market: Regional outlook and key takeaways
Fig. 37 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 Kuwait market estimates and forecasts, 2018-2030 (USD Million)
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Nucleotides: Market outlook
Fig. 8 Nucleotides: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Nucleotides market driver impact
Fig. 14 Nucleotides market restraint impact
Fig. 15 Nucleotides market strategic initiatives analysis
Fig. 16 Nucleotides market: Product movement analysis
Fig. 17 Nucleotides market: Product outlook and key takeaways
Fig. 18 Deoxy Nucleotides market estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 Dideoxynucleotides market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Labelled Nucleotides market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 Nucleotides market: Technology movement analysis
Fig. 23 Nucleotides market: Technology outlook and key takeaways
Fig. 24 TaqMan allelic discrimination market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Gene chips & microarrays market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 SNP by pyrosequencing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Nucleotides market: Application movement analysis
Fig. 29 Nucleotides market: Application outlook and key takeaways
Fig. 30 Pharmaceuticals market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Diagnostics research market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Food & beverage additive market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Animal feed additive market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 Global nucleotides market: Regional movement analysis
Fig. 36 Global nucleotides market: Regional outlook and key takeaways
Fig. 37 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 Kuwait market estimates and forecasts, 2018-2030 (USD Million)
Companies Mentioned
- CJ CHEILJEDANG CORP
- Star Lake Bioscience Co., Inc.
- Thermo Fisher Scientific Inc.
- MEIHUA HOLDINGS GROUP CO., LTD.
- F. Hoffmann-La Roche Ltd.
- Biorigin
- DSM Nutritional Products AG
- Promega Corporation
- Agilent Technologies Inc.
- Lallemand Inc.
- Nanjing Biotogether Co., Ltd.
- NuEra Nutraceuticals Inc.
- Ohly
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | October 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 788.8 Million |
| Forecasted Market Value ( USD | $ 1377.25 Million |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
